These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20639624)

  • 1. Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws.
    Allegra A; Alonci A; Penna G; Granata A; Nastro Siniscalchi E; Oteri G; Loddo S; Teti D; Cicciù D; De Ponte FS; Musolino C
    Acta Haematol; 2010; 124(2):79-85. PubMed ID: 20639624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells.
    Allegra A; Oteri G; Nastro E; Alonci A; Bellomo G; Del Fabro V; Quartarone E; Alati C; De Ponte FS; Cicciù D; Musolino C
    Hematol Oncol; 2007 Dec; 25(4):164-9. PubMed ID: 17577204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteonecrosis of the jaws: a secondary effect of bisphosphonates].
    Schortinghuis J; Meijndert L; De Visscher JG; Witjes MJ
    Rev Belge Med Dent (1984); 2007; 62(4):168-75. PubMed ID: 18506991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
    Hansen T; Kunkel M; Weber A; James Kirkpatrick C
    J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM
    J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?
    Zavras AI; Zhu S
    J Oral Maxillofac Surg; 2006 Jun; 64(6):917-23. PubMed ID: 16713806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
    Favia G; Pilolli GP; Maiorano E
    J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study.
    Perrotta I; Cristofaro MG; Amantea M; Russo E; De Fazio S; Zuccalà V; Conforti F; Amorosi A; Donato G; Tripepi S; Giudice M
    Ultrastruct Pathol; 2010 Aug; 34(4):207-13. PubMed ID: 20594040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A time for perspective on bisphosphonates.
    Assael LA
    J Oral Maxillofac Surg; 2006 Jun; 64(6):877-9. PubMed ID: 16713799
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
    Ficarra G; Beninati F; Rubino I; Vannucchi A; Longo G; Tonelli P; Pini Prato G
    J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.